Evidence map›Paper›PMID 20601633›Full record

ReviewProceedings of the American Thoracic Society2010

Mitigation of chlorine lung injury by increasing cyclic AMP levels.

Gary W Hoyle

Open access · greenAbstract readReview
In one paragraph

Review in Proceedings of the American Thoracic Society, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. The long road to Ithaca: a physiologist's journey.American journal of physiology. Cell physiology · 2025
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Nitrite therapy improves survival postexposure to chlorine gas.American journal of physiology. Lung cellular and molecular physiology · 2014
    Article
  12. Article
  13. Article
  14. Article
  15. Chlorine induces the unfolded protein response in murine lungs and skin.American journal of respiratory cell and molecular biology · 2013
    Article
  16. Review
  17. Targeted aerosolized delivery of ascorbate in the lungs of chlorine-exposed rats.Journal of aerosol medicine and pulmonary drug delivery · 2012
    Article
  18. Article
  19. Article
  20. Integrative assessment of chlorine-induced acute lung injury in mice.American journal of respiratory cell and molecular biology · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Gary W HoyleDepartment of Environmental and Occupational Health Sciences, School of Public Health and Information Sciences, University of Louisville, 319 Abraham Flexner Way, Louisville, KY 40202, USA. Gary.Hoyle@louisville.edu
University of Louisville · US

Funding

Novel Therapies for Chlorine-Induced Lung InjuryU01ES015673 · NIEHS · UNIVERSITY OF LOUISVILLE · PI HOYLE, GARY W. · 2006 to 2015
$4.6M
NIEHS NIH HHS U01 ES015673
6 · The paper itself

Abstract

Chlorine is considered a chemical threat agent to which humans may be exposed as a result of accidental or intentional release. Chlorine is highly reactive, and inhalation of the gas causes cellular damage to the respiratory tract, inflammation, pulmonary edema, and airway hyperreactivity. Drugs that increase intracellular levels of the signaling molecule cyclic AMP (cAMP) may be useful for treatment of acute lung injury through effects on alveolar fluid clearance, inflammation, and airway reactivity. This article describes mechanisms by which cAMP regulates cellular processes affecting lung injury and discusses the basis for investigating drugs that increase cAMP levels as potential treatments for chlorine-induced lung injury. The effects of beta(2)-adrenergic agonists, which stimulate cAMP synthesis, and phosphodiesterase inhibitors, which inhibit cAMP degradation, on acute lung injury are reviewed, and the relative advantages of these approaches are compared.

Indexed as

Adrenergic beta-AgonistsAnimalsChlorineCyclic AMPGasesHumansInhalation ExposureLungLung DiseasesMiceModels, AnimalPhosphodiesterase InhibitorsAdrenergic beta-AgonistsChlorineCyclic AMPGasesPhosphodiesterase Inhibitors

Identifiers

PMID20601633
PMCPMC3136965
OpenAlexW1987254353

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.